Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

NGL Fine-Chem Ltd (NGLFINE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524774 NSE: NGLFINE Pharmaceuticals & Drugs | Small Cap | NGL Fine-Chem Share Price

₹2,713.20 -17.30 (-0.63%)

As on 22-Sep'26 12:12

NGL Fine-Chem Ltd (NGLFINE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524774 NSE: NGLFINE Pharmaceuticals & Drugs | Small Cap | NGL Fine-Chem Share Price

₹2,713.20 -17.30 (-0.63%)

As on 22-Sep'26 12:12

Key Metrics
Valuation Multiples
Market Cap
₹1,687 Cr.
Current Price
₹2,713.2
52-Week Low / High
₹1,261 / 3,595
TTM EPS
₹92.6
TTM Sales
₹536 Cr.
Book Value per Share
₹562.7
P/E Ratio
29.49
Lower than its 5-year historical median
Industry PE
55.1
Price to Book (P/B)
4.85
In line with its 5-year historical median
Price to Sales (P/S)
3.15
Lower than its 5-year historical median
EV/EBITDA
17.91
Lower than its 5-year historical median
Dividend Yield
0.06%
Profitability Efficiency
Return on Equity (ROE)
15.74%
Outperforms industry median
Return on Capital Employed (ROCE)
16.88%
Outperforms industry median
Return on Assets (ROA)
9.60%
Operating Profit Margin
16%
Net Profit Margin
9.61%
Gross Profit Margin
16.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
36.04%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
110.84%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
127.89%
Asset Quality
Promoter Holding
72.49%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹345 Cr.
Equity
₹3.1 Cr.
Face Value
₹5
All Time Low / High
₹0.40 / 3789.45

NGL Fine-Chem stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Somewhat Good
Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Weak
Check Price chart
Q.1 Is NGL Fine-Chem Ltd a good quality company?
NGL Fine-Chem Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does NGL Fine-Chem Ltd performance compare with that of its Peers?
Q.1 Revenue growth of NGL Fine-Chem Ltd vs industry peers?
NGL Fine-Chem Ltd revenue CAGR is 14.19%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of NGL Fine-Chem Ltd?
Promoters hold 72.49% of the NGL Fine-Chem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of NGL Fine-Chem Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 22.3% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
NGL Fine-Chem Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ33.8%21.7%27.6%13.7%51.9%34.7%11.5%18.9%8.3%15%-
Value Creation
Index ⓘ		1.40.61.00.02.71.5-0.20.4-0.40.1-

Growth Parameters ⓘ
Sales ⓘ99.7114153152258319275329359489525
Sales YoY Gr.-14%34.8%-0.7%69.7%23.4%-13.7%19.6%9.2%36%-
Adj EPS ⓘ22.918.62916.688.184.629.458.426.465.981.6
YoY Gr.--18.9%56%-42.7%430%-4%-65.2%98.4%-54.8%149.3%-
BVPS (₹) ⓘ96.2116.6149.1163.8251.6334.4365425.4452.6517.9544.5
Adj Net
Profit ⓘ		14.211.517.910.354.552.318.236.116.340.750
Cash Flow from Ops. ⓘ9.922.48.919.626.615.831.911.12234.7-
Debt/CF from Ops. ⓘ2.31.23.11.40.61.913.13.53.5-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ19.3%13.6%21.1%36%
Adj EPS ⓘ12.4%-5.7%30.8%149.3%
BVPSⓘ20.6%15.5%12.4%14.4%
Share Price 22.2% -1.4% 10.8% 91.3%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ		27.317.521.810.642.428.98.414.8613.615.4
Op. Profit
Mgn % ⓘ		25.61921.115.229.820.710.413.67.513.913.6
Net Profit
Mgn % ⓘ		14.210.111.76.821.116.46.6114.58.39.6
Debt to
Equity ⓘ		0.40.40.30.30.10.20.10.10.30.4-
Working Cap
Days ⓘ		18719816718413216621618619416991
Cash Conv.
Cycle ⓘ		8165557949749976767443

Valuation of NGL Fine-Chem - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales153152258318278339368501
Operating Expenses ⓘ + 121132178249243285333428
Manufacturing Costs2228284543556683
Material Costs6364102147140159182239
Employee Cost 2124283537455666
Other Costs ⓘ 1516192223262940
Operating Profit ⓘ 3220806835543573
Operating Profit Margin (%) 21.1%13.0%31.1%21.5%12.6%15.9%9.4%14.6%
Other Income ⓘ + 43811614915
Exceptional Items ⓘ 00000000
Interest ⓘ 33222235
Depreciation ⓘ 6881011121220
Profit Before Tax ⓘ 2812786727542863
Tax ⓘ 742117713715
Profit After Tax 208575020412148
PAT Margin (%) 13.1%5.5%22.0%15.7%7.4%12.2%5.7%9.6%
Adjusted EPS (₹)32.613.191.680.733.066.634.277.9
Dividend Payout Ratio (%)5.40%13.30%1.90%2.20%5.30%2.60%5.10%2.30%
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 9299154203223263282329
Share Capital ⓘ 33333333
Reserves ⓘ 8996151200219260279326
Debt +23231127303273108
Long Term Debt8863212556
Short Term Debt151552328324852
Minority Interest00000000
Trade Payables1621303725495265
Others Liabilities ⓘ 181112109113458
Total Liabilities ⓘ 149154207277287356442560

Fixed Assets

Net Fixed Assets ⓘ +616864898886143164
Gross Block749296130139148217256
Accumulated Depreciation1324324151637491
CWIP ⓘ 0012626465095
Investments ⓘ 911292939546039
Inventories1928385627435170
Trade Receivables33263864669083131
Cash Equivalents 335113255
Others Assets ⓘ 2518223227365156
Total Assets ⓘ 149154207277287356442560
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + 920271435203243
PBT ⓘ 2812786727542863
Adjustment ⓘ 81251112121326
Changes in Working Capital ⓘ -19-0-34-473-33-2-31
Tax Paid ⓘ -7-4-21-17-7-13-7-15
Cash Flow From Investing Activity ⓘ + -10-20-25-14-27-27-70-71
Capex -14-15-17-29-30-29-74-86
Net Investments 001000-518
Others ⓘ 5-5-8153210-2
Cash Flow From Financing Activity ⓘ + 0-1-1-1-1-13730
Net Proceeds from Shares ⓘ 00000000
Net Proceeds from Borrowing ⓘ 0000002531
Interest Paid ⓘ 000000-2-4
Dividend Paid ⓘ 0-1-1-1-1-1-1-1
Others ⓘ 000000164
Net Cash Flow ⓘ -1-02-17-702
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)21.858.7244.7627.99.6317.037.7515.74
ROCE (%)25.2511.9353.5333.9111.9620.389.4416.88
Asset Turnover Ratio1.0311.431.310.991.050.921
PAT to CFO Conversion(x)0.452.50.470.281.750.491.520.9
Working Capital Days
Receivable Days78.9071.4045.1058.4085.2083.8085.5077.90
Inventory Days44.405646.505454.5037.9046.9044.30
Payable Days9098.8078.7072.4075.7085.10101.5088.90

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

NGL Fine-Chem Ltd FAQs

The current trading price of NGL Fine-Chem on 22-Sep-2026 12:12 is ₹2,713.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Sep-2026 the market cap of NGL Fine-Chem stood at ₹1,686.9 Cr

The latest P/E ratio of NGL Fine-Chem as of 21-Sep-2026 is 33.44.

The latest P/B ratio of NGL Fine-Chem as of 21-Sep-2026 is 5.01.

The 52-week high of NGL Fine-Chem is ₹3,595 and the 52-week low is ₹1,261.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of NGL Fine-Chem is ₹525 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that NGL Fine-Chem Ltd is a average quality company.

The key valuation ratios of NGL Fine-Chem Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of NGL Fine-Chem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About NGL Fine-Chem Ltd

NGL Fine-chem  is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.

Utilizing its expertise in complex multi-stage organic synthesis, it continues to expand the product portfolio with new products.

It has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant technological upgradation.

NGL Fine-chem Ltd has a strong focus on developing intellectual property as a key differentiator and as a platform for further growth up the pharma value chain. It respect intellectual property and invest in developing it as a key growth driver for the future.

Product range of the company includes:

Pharmaceutical like Diminazene Aceturate, Diminazene Diaceturate, Homidium Chloride, Nitroxynil, Clorsulon, Homidium Bromide, Parvaquone, Carprofen, Buparvaquone and Isometamidium Chloride Hydrochloride for:

  • Animal health
  • Human health
  • Intermediate- 4 Aminobenzamidine Dihydrochloride, 3 Aminobenzamidine Dihydrochloride, Ezetimibe Intermediates etc
  • Finished dosages form- Homidium Chloride Tablets, Diminazene Aceturate Granules

Achievements/ recognition

An ISO 9001:2000 accredited company

You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now